|
|
|
| Effect of Acupuncture Combined with rTMS on Post-stroke Comorbid Anxiety and Depression and its Impact on Patients' Serum 5-HT and Hcy Levels |
| LYU Min, YU Xiao-lei, WEN Hui-jun |
| Department of Rehabilitation Medicine, Baoji Traditional Chinese Medicine Hospital,Baoji Shaanxi 721000 |
|
|
|
|
Abstract 【Objective】To investigate the therapeutic effect of acupuncture combined with rTMS on post-stroke comorbid anxiety and depression (PSCAD), and its impact on patients' serum 5-hydroxytryptamine (5-HT) and homocysteine (Hcy) levels. 【Methods】A total of 76 PSCAD patients were randomly divided into the observation group and the control group, with 38 cases in each. Based on the routine symptomatic treatment, the control group was given acupuncture treatment, while the observation group was given acupuncture combined with rTMS treatment. Both groups were treated for 8 weeks on an outpatient basis. The scores of Hamilton Depression Scale(HAMD) and Hamilton Anxiety Scale(HAMA), inflammatory factors [interleukin (IL)-2, IL-6, tumor necrosis factor-α (TNF-α)], neuro-damage indicators [neuron-specific enolase (NSE), brain-derived neurotrophic factor (BDNF), and neuropeptide Y (NPY)], and serum 5-HT and Hcy levels were compared before treatment and 8 weeks after treatment in both groups. 【Results】After treatment, the HAMA and HAMD scores in both groups were reduced compared to pre-treatment (P<0.05), and the scores in the observation group were lower than that in the control group (P<0.05). After treatment, the levels of IL-2, IL-6, TNF-α, NSE, and Hcy were decreased compared to pre-treatment (P<0.05), and their levels in the observation group were lower than those in the control group (P<0.05). After 8 weeks of treatment, the levels of BDNF, NPY, and 5-HT were increased compared to pre-treatment (P<0.05), and the levels in the observation group were higher than those in the control group (P<0.05). 【Conclusion】The combined treatment of acupuncture and rTMS can effectively improve the negative emotions of PSCAD patients, inhibit the inflammatory response, alleviate neuro-damage, and regulate serum 5-HT and Hcy levels.
|
|
Received: 06 January 2023
|
|
|
|
|
|
[1] GUO J, WANG J, SUN W, et al. The advances of post-stroke depression:2021 update[J].J Neurol,2022, 269(3):1236-1249.
[2] ALMHDAWI K A, ALAZRAI A, KANAAN S, et al. Post-stroke depression, anxiety, and stress symptoms and their associated factors:A cross-sectional study[J].Neuropsychol Rehabil,2021, 31(7):1091-1104.
[3] SEBESTOVA M, LACKNER I, INAYAT M, et al. Post stroke depression[J].Ther Umsch,2021, 78(6):299-304.
[4] 金蓓, 王恩龙. 卒中后焦虑抑郁共病中西医研究进展[J].中医药临床杂志, 2022, 34(1):194-198.
[5] HORDACRE B, COMACCHIO K, WILLIAMS L, et al. Repetitive transcranial magnetic stimulation for post-stroke depression:a randomised trial with neurophysiological insight[J].J Neurol,2021, 268(4):1474-1484.
[6] SCHÖTTKE H, GIABBICONI C M. Post-stroke depression and post-stroke anxiety:prevalence and predictors[J].Int Psychogeriatr,2015, 27(11):1805-1812.
[7] 张明园. 精神科评定量表手册[M]. 2版.长沙:湖南科学技术出版社, 1998:35-39.
[8] 王华, 杜元澈. 针灸学[M]. 北京:中国中医药出版社, 2012:20-120.
[9] LEUNG A, SHIRVALKAR P, CHEN R, et al. Transcranial magnetic stimulation for pain, headache, and comorbid depression:INS-NANS expert consensus panel review and recommendation[J].Neuromodulation,2020, 23(3):267-290.
[10] LEFAUCHEUR J P, ALEMAN A, BAEKEN C, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS):An update (2014-2018)[J].Clin Neurophysiol,2020, 131(2):474-528.
[11] LIEGEY J S, SAGNIER S, DEBRUXELLES S, et al. Influence of inflammatory status in the acute phase of stroke on post-stroke depression[J].Rev Neurol (Paris),2021, 177(8):941-946.
[12] 庄超波. 艾司西酞普兰联合高频经颅磁刺激治疗脑卒中后抑郁患者的效果及其作用机制研究[J].中国医师杂志, 2022, 24(10):1586-1589. |
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2023, 40(8): 1259-1261. |
|
|
|
|
2023, Vol. 40 
